Theiler's murine encephalomyelitis (TME) of susceptible mouse strains is a commonly used infectious animal model for multiple sclerosis. The study aim was to test the hypothesis whether cytotoxic T cell responses account for the limited impact of regulatory T cells on antiviral immunity in TME virus-induced demyelinating disease (TMEV-IDD) resistant C57BL/6 mice. TME virus-infected C57BL/6 mice were treated with (i) interleukin-2/-antiinterleukin-2-antibody-complexes to expand regulatory T cells ("Treg-expansion"), (ii) anti-CD8-antibodies to deplete cytotoxic T cells ("CD8-depletion") or (iii) with a combination of Treg-expansion and CD8-depletion ("combined treatment") prior to infection. Results showed that "combined treatment", but neither sole "Treg-expansion" nor "CD8-depletion," leads to sustained hippocampal infection and virus spread to the spinal cord in C57BL/6 mice. Prolonged infection reduces myelin basic protein expression in the spinal cord together with increased accumulation of b-amyloid precursor protein in axons, characteristic of myelin loss and axonal damage, respectively. Chronic spinal cord infection upon "combined treatment" was also associated with increased T and B cell recruitment, accumulation of CD107b 1 microglia/macrophages and enhanced mRNA expression of interleukin (IL)-1a, IL-10 and tumor necrosis factor a. In conclusion, data revealed that the suppressive capacity of Treg on viral elimination is efficiently boosted by CD8-depletion, which renders C57BL/6 mice susceptible to develop chronic neuroinfection and TMEV-IDD.
INTRODUCTION
Multiple sclerosis (MS), one of the most frequent central nervous system (CNS) diseases in young adults, is a chronic demyelinating disease of unknown etiology and possibly multifactorial causes. Based on the generation of myelin-specific immune responses, MS is regarded as an autoimmune disease (3, 64) , presumably triggered by virus infection (30, 61) . Because of the clinical and pathological similarities, Theiler's murine encephalomyelitis (TME) represents a commonly used infectious animal model for the chronic-progressive form of MS in humans (14, 57, 59 ). Theiler's murine encephalomyelitis virus (TMEV) is a single-stranded RNA virus of the genus Cardiovirus (family Picornaviridae). Infection of susceptible SJL mice with the low neurovirulent BeAn-strain causes an acute transient polioencephalitis (44) , followed by virus persistence with immune-mediated myelin loss in the spinal cord (TMEV-induced demyelinating disease [TMEV-IDD]) (27, 44, 52, 58, 84, 85) . In contrast, TMEV-IDD-resistant C57BL/6 mice eliminate the virus from the CNS by specific cellular immunity (60) , especially by effective CD8-mediated cytotoxicity directed against viral epitopes of the VP2 protein (5, 29) . The central role of early cytotoxicity has been demonstrated by studies in mice lacking CD8
1 T cells, which develop TMEV-persistence and demyelinating disease despite the resistant C57BL/6 background (62, 71, 72) . Furthermore, transfer of virus-specific CD8
1 T cells to susceptible SJL mice results in virus clearance and prevention of demyelinating disease (21, 56) .
Regulatory T cells (Treg), characterized by the expression of the transcription factor forkhead box P3 (Foxp3), play a key role in the maintenance of immunological tolerance and can prevent immunopathology (75, 76) . However, in viral diseases Treg can exhibit dual functions with beneficial effects by reducing immunemediated tissue damage and detrimental effects because of their immunosuppressive properties, causing disease exacerbation and viral persistence (10, 17, 42, 45-47, 69, 70, 83, 94) . Therefore, a detailed knowledge about antiviral immunity, immune-mediated damage and viral replication kinetics is required for the use of therapeutic Treg-modulating strategies in CNS disorders.
Treg contribute to impaired virus-specific responses in the Friend retrovirus mouse model (100) and experimental herpesvirus infection (17, 82) of mice by inhibiting virus-specific CD8 1 T cells. Similarly, an imbalance between Treg and CD8 1 T cell responses during the acute infection phase is supposed to contribute to virus persistence in TMEV-IDD-susceptible SJL mice (70) . Accordingly, rapid expansion of Treg has been demonstrated in the brain of susceptible SJL mice but not in resistant C57BL/6 mice following TMEV-infection (24, 70) . Moreover, functional Treginactivation by anti-CD25-antibodies prior to infection results in enhanced virus-specific immunity, reduced viral load and delayed disease progression, while adoptive transfer of ex vivo-expanded Treg leads to disease exacerbation in TMEV-infected SJL mice (50, 70) . However, these Treg-modulating strategies have failed to influence the disease course in C57BL/6 mice, demonstrating the complexity of antiviral immunity in TMEV-IDD-resistant mouse strains. In addition, in a previous study we did not observe any effect on virus clearance in TMEV-infected transgenic DEREG mice (BAC-transgenic Foxp3 reporter mice on C57BL/6 background) following ablation of Foxp3 1 Treg during the acute disease phase, despite strong effector T cell responses (67) .
The study aim was to test the hypothesis that strong cytotoxic T cell responses account for the limited impact of Treg on antiviral immunity in TMEV-IDD-resistant mice. For this purpose, the effects of in vivo Treg-expansion, in vivo CD8-depletion and a combination of both treatments prior to TMEV infection were compared. Results revealed that the suppressive capacity of in vivoexpanded Treg on viral elimination is efficiently boosted by CD8-depletion, which leads to sustained hippocampal infection and increased virus spread to the spinal cord.
MATERIALS AND METHODS

Experimental design
Female C57BL/6JOlaHsd and SJL/JCrHsd mice were purchased from Harlan. At the age of 5 weeks, mice were inoculated in the right cerebral hemisphere with 1.14 3 10 5 plaque forming units of the BeAn strain of TMEV diluted in 20 mL Dulbecco's modified Eagle Medium (PAA Laboratories) with 2% fetal calf serum (GE Healthcare Laboratories) and 50 mg/kg gentamicin (SigmaAldrich). TMEV was kindly provided by Prof. Dr. H. L. Lipton (Department of Neurology, Northwestern University Medical School, Chicago). For intracerebral injection, mice were anesthetized with medetomidine (0.5 mg/kg, Dormitor, Orion Pharma) and ketamine (100 mg/kg, Ketamine 10%, WDT eG).
A clinical examination of the animals was performed weekly and symptoms were assessed using a three-tiered score including (a) general appearance (0 5 normal posture, smooth and shiny hair, 1 5 normal posture, shaggy and dull hair, 2 5 slightly hunched back, shaggy and dull hair, 3 5 severely hunched back, unkempt appearance, incontinence), (b) behavior (0 5 alert and curious, 1 5 very quiet, mildly reduced spontaneous movement, no reduction of induced movement, 2 5 moderately reduced spontaneous movement, slightly reduced induced movement, 3 5 no or minimal spontaneous or induced movement), (c) gait abnormalities (0 5 normal gait, 1 5 mild ataxia with inconsistent waddling gait, 2 5 moderate ataxia with consistent waddling or stiff gait and paddling tail, 3 5 severe ataxia with stiff or sliding gait and reduced righting response, and 4 5 severe ataxia and paresis of the hind legs), as described previously (88) . Animals were euthanized prior to the experimental endpoint, if they reached a score of 3 in the categories "general appearance" and/or "behavior," a score of 4 in the category "gait abnormalities" or if they lost 20% of body weight for animal welfare purposes.
72 C57BL/6 mice in groups of 4-7 mice were euthanized at 3, 14 and 42 days post infection (dpi) with an overdose of medetomidine (2 mg/kg) and ketamine (400 mg/kg) following anesthesia as described above. In addition, 5 infected SJL mice, representing a TMEV-IDD susceptible mouse strain, were euthanized at 42 dpi for comparison with spinal cord inflammatory responses induced in treated C57BL/6 mice. For characterizing changes in peripheral lymphoid organs under steady state conditions, 48 non-infected C57BL/6 mice were euthanized at 3, 7 and 14 days of treatment. Animals were perfused via the left ventricle of the heart with phosphate buffered saline (PBS). Blood samples were taken before perfusion and collected for flow cytometric analysis after adding 50 international units of heparin (Heparin-Natrium-5000-ratiopharmV R GmbH). Brain, spinal cord, spleen, thymus and cervical lymph nodes were removed immediately. The cerebrum was cut transversally at the level of optic chiasm and the spinal cord was divided into three parts (cervical, thoracic and lumbar). The caudal part of the cerebrum and one half of each spinal cord segment was fixed in 10% formalin for 24 hours and subsequently embedded in paraffin wax. The rostral part of the cerebrum and parts of each spinal cord segment were snap frozen and stored at 2808C until further use for RNA isolation.
The study was conducted in accordance with German law for animal protection and with the European Communities Council Directive 86/609/EEC for the protection of animals used for experimental purposes and in accordance with the German Animal Welfare Act. All animal experiments were approved and authorized by the Local Institutional Animal Care and Research Advisory committee and permitted by the local authorities (Regierungspr€ asidium, Hannover, Germany, permission numbers: 33.9-42502-04-11/0538 and 33.12-42502-04-13/1138).
Expansion of regulatory T cells and depletion of CD8
1 T cells
To expand regulatory T cells (Treg-expansion) in vivo, animals were treated with interleukin-2/anti-interleukin-2 immune complexes (IL-2C) as described elsewhere (6, 97) . IL-2C consist of 10 mg of anti-IL-2 antibodies (eBiosciences, clone JES6-1A12) mixed with 2 mg murine recombinant IL-2 protein (eBiosciences, catalog number 34-8021), incubated at 378C for 30 minutes before injection. IL-2C were injected intraperitoneally (i.p.) on three consecutive days (day -3, -2 and -1) prior to TMEV-infection on day 0 (group Treg"TMEV).
For depletion of CD8 1 T cells (CD8-depletion), animals received 500 mg anti-CD8 antibodies (12) on three consecutive days (day -3, -2 and -1) i.p. prior to TMEV-infection at day 0 (group CD8#TMEV). For simultaneous Treg-expansion and CD8-depletion (combined treatment), IL-2C and anti-CD8-antibodies were injected with an interval of 6 hours on the same day (group Treg"CD8#TMEV). Control animals received PBS injections i.p. at the same time points (group TMEV).
According to the same application scheme, non-infected C57BL/ 6 mice were either treated with PBS (control), IL-2C (group Treg") or IL-2C and anti-CD8-antibodies (group Treg"CD8#) to investigate the effect of treatment under steady state (non-infectious) conditions.
Histology
Formalin-fixed, paraffin-embedded cerebral and spinal cord tissue was sectioned at 2 mm thickness and stained with hematoxylin and eosin (HE). The cerebrum was sectioned coronally at the level of bregma 21.46 to 21.82 (65) . Myelitis was determined by evaluating the spinal cord segments: cervical, thoracic and lumbar. A semiquantitative scoring system based on the degree of perivascular infiltration (0 5 no changes, 1 5 one layer, 2 5 two to three layers, 3 5 more than three layers of inflammatory cells) and hypercellularity (0 5 no change, 1 5 1-25 cells, 2 5 26-50 cells, 3 5 >50 cells) was applied as described previously (18, 19, 24) . The total myelitis score was determined by adding the scores of all three segments for each animal.
Immunohistochemistry
For immunohistochemistry, antibodies detecting viral protein (TMEV), Foxp3 (Treg), CD3 (T cells), CD107b (microglia/macrophages), CD45R (B cells), b-amyloid precursor protein (b-APP; damaged axons) and myelin basic protein (MBP) were used on paraffin-embedded sections. Antibodies detecting CD4 ] using the analySISV R 3.2 software. To detect small, randomly distributed foci of myelin loss (MBP) and axonal damage (b-APP), four cross sections per spinal cord segment (cervical, thoracic, lumbar) were evaluated in each animal.
Flow cytometry
Spleen samples were dissolved to single cell suspension in PBS containing 0.2 % bovine serum albumin (PBS/BSA; Gibco) using a 100 mm sieve and centrifuged (330 3 g, 10 minutes, room temperature). Erythrocytes were lysed by adding 1 mL ammonium- chloride-potassium lysing buffer (Gibco) for 2 minutes at room temperature. Cells were washed, resuspended and filtered (30 mm) in PBS/BSA. The cell number was determined and 2 3 10 6 cells were used of each sample. For erythrocyte lysis of blood samples, 75 mL of heparin-blood were mixed with 2 mL lysing buffer and incubated for 4 minutes at room temperature. Lysis reaction was stopped by adding 3 mL RPMI 1640 medium with L-glutamine (Gibco) with 10% of fetal calf serum (Biochrom AG) and 50 U/mL Penicillin-streptomycin (Gibco). Samples were centrifuged (330 3 g, 8 minutes, 48C), supernatants were discarded and cells were washed in 3 mL PBS/BSA (Gibco). Blood and spleen cells were stained as follows: For FcgR blockade, 100 mL of Fcy block medium (BioXcell, 2.4G2, 1:100, diluted in PBS with 0.02% sodium azide) were added to each tube, incubated for 5 minutes at 48C and washed in PBS/BSA. Live/dead staining was performed using the LIVE/DEAD Fixable Blue Dead Cell Stain Kit (Invitrogen, 1:500, diluted in PBS). About 100 mL were added to each tube, samples were incubated for 30 minutes at 48C and washed in PBS/BSA. For cell surface staining, a fourfold concentrated antibody mix detecting helper T cells (CD4) and cytotoxic T cells (CD8) was added. For antibody details see Table 2 . Samples were incubated for 15 minutes at 48C in the dark. Subsequently, cells were washed in 3 mL PBS/BSA. For Foxp3 staining the Foxp3 Transcription Factor Staining Buffer Set (eBioscience) was used. Cells were re-suspended in 1 mL fixation/permeabilization concentrate (fixation permeabilization concentrate/fixation permeabilization diluent 1:3) and incubated for 30 minutes at 48C in the dark. After centrifugation (300 3 g, 8 minutes, 48C) cells were resuspended in 600 mL PBS/BSA and kept at 48C in the dark until further processing. Cells were washed twice with 2 mL of 13 working solution of the permeabilization buffer and supernatants were discarded. About 50 mL permeabilization buffer, including rat IgG ([40 mg/mL], Jackson Immuno Research) were added and samples were incubated for 15 minutes at 48C in the dark. Subsequently, without washing, 100 mL permeabilization buffer and the anti-Foxp3 antibody were added and incubated for 30 minutes at 48C in the dark. Afterward, samples were washed in permeabilization buffer and 400 mL of permeabilization buffer were added. Samples were incubated for 5 minutes at room temperature in the dark and centrifuged (1400 rpm, 4 minutes, 48C). Finally, cells were re-suspended in PBS/BSA, filtered and stored at 48C in the dark until use. For flow cytometry, a LSRII SORP cytometer (BD Biosciences) was used and data were analyzed using FlowJo software version 9.6.4 (Tree Star).
Ribonucleic acid isolation and reverse transcription
Snap frozen brain and spinal cord tissues were cut and ribonucleic acid (RNA) was isolated from 10 to 40 mg tissue of each brain/spinal cord using an Omni's PCR Tissue Homogenizing Kit (S€ udLaborbedarf GmbH), QIAzol V R lysis reagent and RNeasy V R Mini Kit (Qiagen). RNA sample quality and amount of RNA was measured by applying a NanoDrop 1000 spectrophotometer (Thermo Fischer Scientific). Equal amounts of RNA were subsequently transcribed into cDNA with the Omniscript TM RT Kit (Qiagen), RNaseOUT TM , Recombinant Ribonuclease Inhibitor (life technologies) and random primers (Promega). For reverse transcription, the following thermocycler program was used: 10 minutes at 258C, followed by 1 hour at 378C and at the end 5 minutes at 938C.
Polymerase chain reaction
Reverse transcription quantitative polymerase chain reaction (RTqPCR) for the quantification of viral RNA (TMEV) and the three reference genes glyceraldehyde 3-phosphate dehydrogenase (GAPDH), b-actin and hypoxanthine-guanine phosphoribosyltransferase (HPRT) in brain and spinal cord tissues was performed using the Mx3005P TM Multiplex Quantitative PCR System (Agilent Technologies) and Brilliant III SYBR Table 3 . For quantification, 10-fold serial dilution standards ranging from 10 8 to 10 2 copies/mL were prepared. The normalization factor for correction of experimental variations was calculated from the three reference genes with geNorm software version 3.4 (93) . Specificity of each reaction was controlled by melting curve analysis.
Statistical analyses
For statistical analysis of non-normal distributed data, multiple Mann-Whitney U-tests were performed to determine any difference between treatment groups. A P-value of 0.05 was considered as being statistically significant. Analyses were performed using SPSS for windows (SPSS Inc.). Graphs were created with GraphPad Prism V R (GraphPad Software).
RESULTS
Expansion of regulatory T cells maintains virus infection in the brain following depletion of CD8 1 T cells in C57BL/6 mice
To elucidate the effect of Treg-cytotoxic T cell interplay on antiviral immunity in TMEV-IDD-resistant C57BL/6 mice, Foxp3 1 Treg were expanded by IL-2C application (Treg-expansion) with and without simultaneous antibody-mediated depletion of CD8 1 T cells. Anti-CD8-antibody (aCD8)-treated mice and combined treated mice (groups CD8#TMEV and Treg"CD8#TMEV) exhibited significantly elevated virus RNA levels compared to untreated controls (group TMEV) at 3 dpi ( Figure 1A ). Strikingly, Treg-expansion together with CD8-depletion (group Treg"CD8#TMEV) delayed viral elimination, showing significantly increased virus RNA concentrations in the brain compared to all other groups at 14 dpi (Figure 1A, Supporting Information Table S1 ). Subsequently, at 42 dpi, virus RNA decreased in combined treated mice, but was still detectable and significantly higher compared to groups Treg"TMEV and CD8#TMEV ( Figure 1A ). Although increased virus RNA levels were also found at 14 dpi following CD8-depletion (group CD8#TMEV) with significantly more TMEV RNA copies than found in Treg-expanded mice (group Treg"TMEV), values did not reach the level of significance compared to untreated controls (group TMEV) ( Figure 1A , Supporting Information Table S1 ). As expected, untreated, TMEV-infected C57BL/6 mice (group TMEV) nearly cleared the virus after the acute polioencephalitis phase at 42 dpi, as demonstrated by RT-qPCR ( Figure 1A ). Similarly, Tregexpansion alone (group Treg"TMEV) did not alter the amount of viral RNA in the brain compared to group TMEV mice and virus elimination was found at 42 dpi, indicative of sustained effective antiviral immunity ( Figure 1A ). Confirming RT-qPCR results, highest numbers of TMEVinfected cells were found in combined treated mice (group Treg"CD8#TMEV) at 14 dpi ( Figure 1B) . Notably, an increased infection of the hippocampal pyramidal cell layer was noticed in Treg-expanded mice (group Treg"TMEV) compared to untreated infected mice (group TMEV) at 14 dpi.
Immunohistochemistry and histology revealed that TMEVinfection and inflammatory responses were largely restricted to the hippocampus as described before (51) Taken together, concurrent antibody-mediated depletion of CD8
1
T cells potentiates the ability of Treg-expansion to reduce antiviral responses in C57BL/6 mice during the early TME phase. Spatiotemporal analyses revealed that delayed viral elimination in combined treated mice is associated with a higher TMEV load in the hippocampus.
CD8-depletion leads to an enhanced recruitment of Foxp3 1 regulatory T cells to the infected hippocampus
Immunohistochemistry was performed to characterize dynamic changes of cellular responses and quantify accumulating immune cells in the hippocampus associated with Treg-and/or CD8-modulation. In all treatment groups, acute hippocampal infection (3 dpi) was dominated by CD3
1 T cells with significantly increased T cell numbers following Treg-expansion alone (group Treg"TMEV; Figure 3A -C, Supporting Information Table S1 ). Similarly, significantly enhanced infiltration of Foxp3 1 Treg was found in Tregexpanded mice at 3 dpi ( Figure 3D ). Remarkably, despite reduced CD3 1 T cell infiltration in both aCD8-treated groups (groups CD8#TMEV and Treg"CD8#TMEV), CD8-depletion combined with Treg-expansion significantly increased the amount of infiltrating Foxp3
1 Treg in the hippocampus compared to controls at 3 dpi. Associated with this, a significantly increased Foxp3 mRNA expression was found in combined treated mice compared to all other groups ( Figure 3E ). Probably attributed to termination of prolonged hippocampal inflammation, significantly elevated numbers of Foxp3
1 Treg together with elevated Foxp3 mRNA levels were found in the hippocampus of both aCD8-treated groups (group CD8#TMEV and Treg"CD8#TMEV; Figure 3D -F, Supporting Information Table S1 ) also at 42 dpi.
In contrast to T cells, CD45 1 B cell infiltration was significantly reduced in the hippocampus following Treg-expansion (group Treg"TMEV) compared to untreated mice (group TMEV) at 3 dpi. Sustained brain infection in combined treated mice (group Treg"CD8#TMEV) led to significantly increased CD45R 1 B cell numbers at 14 dpi. Increased numbers of CD45R 1 B cells, significantly different from group Treg"TMEV, were also found in aCD8-treated (group CD8#TMEV) and combined treated mice (group Treg"CD8#TMEV) at 42 dpi ( Figure 3G -I, Supporting Information Table S1 ). CD8-depletion (group CD8#TMEV) significantly decreased the amount of CD107b 1 cells during acute TMEV infection (3 dpi). In parallel with virus load kinetics, CD107b 1 microglia/ macrophage accumulation peaked at 14 dpi in combined treated mice (group Treg"CD8#TMEV) with significantly increased values compared to all other groups ( Figure 3J -L, Supporting Information Table S1 ).
In summary, data confirmed that in vivo Treg-expansion by IL-2C treatment transiently increases the CNS recruitment of Foxp3 1 Treg during acute TMEV-infection, which is markedly enhanced by CD8-depletion. Phenotypical analyses also revealed that prolonged hippocampal infection in combined treated C57BL/6 mice is associated with enhanced CD107b 1 microglia/macrophage responses and CD45R
1 B cells infiltration. Inflammatory responses in the brain were further quantified by cytokine expression analyses. RT-qPCR revealed a significantly increased transcription of the pro-inflammatory cytokines IL-1a and TNF-a in both aCD8-treated groups (group CD8#TMEV and Treg"CD8#TMEV) at 14 dpi with highest values found in combined treated mice ( Figure 4A,B) . Similarly, IL-2 mRNA levels were significantly elevated in combined treated mice at 14 dpi (Figure 4C) . IL-23 mRNA levels were transiently decreased in aCD8-treated mice (group CD8#TMEV) at 3 dpi and increased in Tregexpanded mice (group Treg"TMEV) at 14 dpi. Notably, a significantly increased IL-23 transcription was measured in both aCD8-treated groups (group CD8#TMEV and Treg"CD8#TMEV) at 42 dpi ( Figure 4D) , indicative of prolonged inflammatory responses in the brain. Anti-inflammatory IL-10 and TGF-b mRNA expression was highest in aCD8-treated mice with Treg-expansion (group Treg"CD8#TMEV) at 14 dpi ( Figure 4E,F) . Together with sustained elevated Foxp3 mRNA expression ( Figure 3E ), prolonged brain infection was also associated with elevated IL-10 mRNA expression in combined treated mice at 42 dpi ( Figure 4E ), characteristic of counter regulatory attempts to reduce neuroinflammation.
Prolonged viral encephalitis promotes virus spread to spinal cord and leukomyelitis in C57BL/6 mice The inability of susceptible SJL mice to clear the virus during the acute encephalitis phase of TMEV-infection is a key step in developing chronic spinal cord infection and TMEV-IDD (63) . Therefore, the question was raised, whether delayed virus elimination from the brain following combined treatment leads to chronic spinal cord infection in resistant C57BL/6 mice. Similar to the brain, prolonged TMEV-infection determined by RT-qPCR was found in the spinal cord of combined treated mice. Group Treg"CD8#TMEV animals displayed significantly more viral copy numbers compared to untreated control mice (group TMEV) and Treg-expanded mice (group Treg"TMEV) at 14 dpi. At 42 dpi, TMEV RNA load was significantly higher in group Treg"CD8#TMEV animals compared to all other groups ( Figure  5A , Supporting Information Table S1 ). Virus RNA was also detected at 14 and 42 dpi in C57BL/6 mice following anti-CD8-antibody treatment alone (group CD8#TMEV), however, values did not reach the level of significance compared to untreated controls or Treg-expanded animals ( Figure 5A , Supporting Information Table S1 ). Similar to viral RNA, TMEV antigen was observed in group CD8#TMEV and group Treg"CD8#TMEV animals at 14 and 42 dpi. However, only combined treated mice (group Treg"CD8#TMEV) showed significantly increased TMEVinfected cell numbers compared to group TMEV and Treg"TMEV ( Figure 5B , Supporting Information Table S1 ).
Immunohistochemistry showed the presence of TMEV protein in spinal cord grey and white matter at 14 dpi ( Figure 5C,D) , while a preferential infection of the spinal cord white matter was found at 42 dpi. Since a cell tropism switch of TMEV from grey matter neurons to white matter cells is a prerequisite for demyelination in TMEV-IDD-susceptible mice (41) spinal cord pathology including integrity of myelin sheaths and axons was evaluated. While histological scoring revealed significant myelitis in aCD8-treated animals compared to group TMEV and group Treg"TMEV at 42 dpi, combined treatment (group Treg"CD8#TMEV) caused an even stronger inflammatory response at 14 and 42 dpi, with significantly increased scores compared to group TMEV and Treg"TMEV at 14 dpi and all other groups at 42 dpi ( Figure 6A ,B and Supporting Information Table S1 ). Multiple inflammatory foci with significantly reduced MBP-staining, indicative of myelin loss, were found in the spinal cord white matter predominantly of both aCD8-treated groups at 42 dpi ( Figure 6C,D) . Significant axonal damage characterized by axonal swelling with b-APP accumulation was found within white matter foci only in combined treated mice (group Treg"CD8#TMEV), indicating detrimental effects on axonal integrity triggered by prolonged virus infection ( Figure 6E ,F, Supporting Information Table S1 ).
Weekly clinical examination revealed no symptoms in groups TMEV, Treg"TMEV and CD8#TMEV at any investigated time point. Interestingly, three out of seven combined treated animals (group Treg"CD8#TMEV) showed mildly to moderately elevated clinical scores (total scores of 1 to 2) starting at 21 dpi. However, statistical analyses revealed only a statistical tendency between treatment groups (P > 0.06, Supporting Information Table S1 ), suggestive of marginal effects of neuropathology upon clinical manifestation in combined treated mice.
Collectively, Treg-expansion together with CD8-depletion (combined treatment) facilitates TMEV spread and chronic infection of the spinal cord in C57BL/6 mice. Viral leukomyelitis is associated with myelin loss and axonopathy as observed in TMEV-IDDsusceptible mouse strains. Figure  6A-C) . In aCD8-treated (group CD8#TMEV) and combined treated mice (group Treg"CD8#TMEV), significantly increased 
numbers of CD3
1 T cells, CD4 1 T cells and CD107b 1 microglia/ macrophages compared to untreated controls (group TMEV) were found at 42 dpi ( Figure 7A-I) . Strikingly, CD8
1 T cells were only elevated in aCD8-treated (group CD8#TMEV) mice at 42 dpi, suggestive of impaired CNS-infiltration of cytotoxic T cells in combined treated mice ( Figure 7E ,F, Supporting Information Table  S1 ). CD45R
1 B cell numbers were significantly increased only in combined treated mice at 42 dpi ( Figure 7J -L, Supporting Box plots display median and quartiles with minimum and maximum values. Significant differences (P 0.05; Mann-Whitney U test) are labeled: * significant difference to group TMEV; # significant difference to group Treg"TMEV; ᭺ significant difference to group CD8#TMEV. TMEV 5 untreated, infected mice; Treg"T-MEV 5 regulatory T cell expanded, infected mice; CD8#TMEV 5 CD8 Information Table S1 ). In comparison to TMEV-IDD susceptible SJL mice, significantly lower numbers of CD3 1 T cells, CD45R
1 B cells and CD107b 1 microglia/macrophages were found in combined treated mice (group Treg"CD8#TMEV) at 42 dpi (Supporting Information Figure S1A -C, Supporting Information Table S2 ).
Inflammatory responses in group CD8#TMEV were accompanied by significant infiltration of Foxp3 1 Treg at 42 dpi ( Figure 7M , Supporting Information Table S1 ). Suggestive of increased Treg responses, significantly elevated numbers of Foxp3 1 Treg together with a raised Foxp3 mRNA expression at 14 and 42 dpi was only found in combined treated mice (group Treg"CD8#TMEV; Figure 7M ,N; Supporting Information Table S1 ). Numbers of Foxp3 1 cells in combined treated mice were not significantly different from those observed in TMEV-IDD susceptible SJL mice (Supporting Information Figure S1D ; Supporting Information Table S2 ).
Inflammatory responses in the spinal cord were further studied by cytokine expression analyses. RT-qPCR showed a significantly increased transcription of the pro-inflammatory cytokines IL-1a and TNF-a at 14 and 42 dpi in combined 
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V C 2017 International Society of Neuropathology treated mice (group Treg"CD8#TMEV) compared to untreated controls and Treg-expanded animals (group TMEV and Treg"TMEV, Figure 8A ,B; Supporting Information Table 1 ). Additionally, TNF-a mRNA levels were significantly higher in combined treated animals than in aCD8-treated animals at 42 dpi ( Figure 8B ; Supporting Information Table S1 ). The antiinflammatory cytokine IL-10 was significantly elevated at 14 and 42 dpi in group Treg"CD8#TMEV compared to untreated controls (group TMEV; Figure 8C , Supporting Information Table S1 ). Other investigated cytokines (IL-2, IL-23 and TGFb) were not differentially expressed at both time points (Supporting Information Table S1 ). The presented data indicate that chronic TMEV-infection in combined treated C57BL/6 mice stimulates innate immune responses mediated by microglia/macrophages and enhances lymphocyte recruitment to the spinal cord.
Early expansion of regulatory T cells impedes recovery of peripheral CD8 1 T cell population during chronic virus infection
To elucidate whether peripheral immune responses are associated with delayed viral elimination in combined treated C57BL/6 mice, the dynamics of CD4 1 Foxp3 1 Treg and CD8 1 T cell populations in blood and spleen during the disease course were analyzed by flow cytometry.
IL-2C application successfully elevated the frequency of circulating CD4 1 Foxp3 1 Treg in blood and spleen samples at 3 dpi with and without concurrent CD8-depletion (group Treg"TMEV and Treg"CD8#TMEV; Figure 9A ,C, Supporting Information Table S1 ). Phenotypic analyses revealed that antibody-mediated CD8-depletion significantly decreased the frequency of CD8 1 T cells in the blood and spleen of TMEV-infected C57BL/6 mice at 3 and 14 dpi (groups CD8#TMEV and Treg"CD8#TMEV; Figure 9B ,D, Supporting Information Table S1 ). Circulating CD8 1 T cell numbers rebounded at 42 dpi in group CD8#TMEV, resulting in frequencies similar to untreated control mice (group TMEV). Notably, blood CD8 1 T cells were still significantly reduced in combined treated mice (group Treg"CD8#TMEV) compared to all other groups at 42 dpi, indicating a delayed recovery of the peripheral CD8
1 T cell population following simultaneous Treg-expansion ( Figure 9D , Supporting Information Table S1 ). Similarly, significantly reduced CD8 1 T cell frequencies compared to all other groups were found in the spleen of combined treated mice (group Treg"CD8#TMEV). Accordingly, the ratio of
1 /CD8 1 cell ratio) was increased in group CD8#TMEV only until 14 dpi while it stayed Box plots display median and quartiles with minimum and maximum values. Significant differences (P 0.05; Mann-Whitney U test) are labeled: * significant difference to group TMEV; # significant difference to group Treg"T-MEV; ᭺ significant difference to group CD8#TMEV. TMEV 5 untreated, infected mice; Treg"TMEV 5 regulatory T cell expanded, infected mice; CD8#TMEV 5 CD8 1 T cell depleted, infected mice; Treg"CD8#T- elevated until 42 dpi in blood and spleen samples of combined treated mice (group Treg"CD8#TMEV) with significantly higher values compared to all other treatment groups ( Figure 9E , Supporting Information Table S1 ). Interestingly, sole Treg-expansion (group Treg"T-MEV) was also able to decrease the frequency of circulating CD8 1 T cells compared to untreated mice (group TMEV) at 14 and 42 dpi in blood samples and at 42 dpi in spleen tissue, respectively. Moreover, significantly increased CD4 
Foxp3
1 /CD8 1 cell ratio values were detected in blood and spleen at 3 and 42 dpi of Treg-expanded mice (group Treg"TMEV).
In order to determine the kinetics of peripheral T cells not expressing Foxp3 (non-Treg), CD4
1 and CD8 1 T cells were gated on Foxp3 2 cells. Data revealed that circulating CD4 1 Foxp3 2 T cells were significantly reduced in group Treg"CD8#TMEV mice compared to group TMEV mice (control) at 3 and 14 dpi (Supporting Information Figure S2A ). Similarly, CD4
1 Foxp3 2 T cells were significantly decreased in spleens of group Treg"TMEV animals at all time points, indicating a primary increase of Foxp3 1 Treg following IL-2C treatment (Supporting Information Figure S2B ). At 42 dpi, a significant increase of splenic CD4 1
2 T cells was detected in aCD8-treated mice with and without Treg-expansion (groups CD8#TMEV and Treg"CD8#TMEV), suggestive of CD4 1 effector T cell expansion associated with prolonged CNS infection. Except from a mild but significant increase of circulating CD8 
2 T cells in Treg-expanded infected mice (group Treg"T-MEV) compared to controls (group TMEV), dynamic changes of CD8 1 Foxp3 2 T cells in blood and spleen samples (Supporting Information Figure S2C ,D) were similar to those found for entire CD8 1 T cell populations ( Figure 9D ), showing only a minor effect of treatment on regulatory CD8 
1 T cells. B cells in spleens were quantified by immunohistochemistry. Densiometric analyses revealed an increase of CD45R 1 B cells in aCD8-treated mice with and without Treg-expansion (groups CD8#TMEV and Treg"CD8#TMEV), suggestive of enhanced humoral immune responses triggered by increased CNS infection (Supporting Information Figure S3 ).
Taken together, analyses demonstrate the ability of a transiently expanded Treg-compartment to induce long-lasting disturbances of the CD8 1 T cell compartment, which potentially promote a chronic CNS infection in combined treated, TMEV infected C57BL/6 mice.
Depletion of CD8
1 T cells potentiates regulatory T cell expansion in peripheral lymphoid organs
Above data indicate that CD8-depletion leads to increased Foxp3 1 Treg responses in the CNS of TMEV-infected mice. To determine whether aCD8-application enhances IL-2C-mediated Treg-expansion in peripheral lymphoid organs, the primary treatment effect was investigated under non-infectious (steady state) conditions ( Figure 10A-D) .
Reduced frequencies of circulating CD8 1 T cells were found at 3, 7, and 14 days after aCD8-application (group Treg"CD8#, Figure 10A ,C, Supporting Information Table S3 ). As described before (6, 97), IL-2C treatment rapidly increases the yield of CD4 
Foxp
1 Treg at 3 dpi (group Treg"CD8#). Data show the ability of concurrent CD8-depletion to transiently enhance peripheral Treg-expansion induced by IL-2C treatment in C57BL/6 mice.
In addition, immunohistochemistry performed at day 3 revealed a significant increase of Foxp3 1 cells in lymphoid organs in combined treated mice (group Treg"CD8#) compared to control animals (spleen, thymus, and cervical lymph node) and animals treated only with IL-2C (group Treg"; spleen and cervical lymph node), indicating generalized Treg-expansion in the peripheral immune system (Supporting Information Table S3 ; Supporting Information Figure S4 ).
DISCUSSION
CD8-mediated cytotoxicity critically controls virus infection and is crucial for disease resistance in the TME model (4, 62) . Results of the present study reveal that early Treg-expansion maintains virus infection in the brain in combination with CD8-depletion, thereby promoting virus spread to the spinal cord and leukomyelitis in TMEV-IDD-resistant C57BL/6 mice.
Besides eliminating TMEV directly (1, 21, 70) , CD8 1 T cell responses seem to reduce the ability of Treg to inhibit antiviral immunity in this MS model. In support of this notion, strong antigenic stimulation of cytotoxic CD8 1 T cells has been shown to Mann-Whitney U test) are labeled: * significant difference to control group; # significant difference to group Treg"; control 5 untreated mice; Treg" 5 regulatory T cell expanded mice; Treg"CD8# 5 combined treated mice.
limit the suppressive capacity of Treg in an OT-I-mediated, oligodendrocyte directed ex vivo mouse model (22) . In TMEV-IDDsusceptible SJL mice, adoptive transfer of Treg during the acute TME phase leads to increased viral replication, decreased CNS leukocyte recruitment and clinical deterioration (50, 70) , while functional inactivation of Treg leads to an increase of TMEV-specific IFN-g producing CD8 1 T cells (70) . However, in TMEV-IDDresistant C57BL/6 mice, adoptive transfer ("gain of function" approach) or genetic ablation and antibody-mediated inactivation of Treg ("loss of function" approaches) have failed to influence viral load in previous studies (50, 67, 70) . In agreement with these reports, the present study showed that in vivo Treg-expansion delayed viral elimination only if CD8
1 cytotoxic T cells were depleted simultaneously.
Simultaneous CD8-depletion and Treg-expansion (combined treatment) caused prolonged infection of pyramidal neurons of the hippocampus of C57BL/6 mice. Associated cellular responses and pro-inflammatory cytokine (IL-1a, IL-2, TNF-a) expression in the brain might initiate antiviral immunity but probably also hippocampal damage (11, 13, 35) . A variety of viruses, such as Borna disease virus, measles virus, neuroadapted Sindbis virus, herpes virus, rabies virus and human immunodeficiency virus have the ability to infect and damage hippocampal neurons, leading to disturbances in the excitatory network and memory system (8, 9, 34) . Notably, also picornaviruses (eg, Coxsackievirus A21) are currently discussed to cause subclinical brain infection and hippocampal damage in human beings (9, 48) . TMEV-infection of C57BL/6 mice has become a valuable model to investigate virus-induced hippocampal damage and infection-induced epilepsy (43, (78) (79) (80) . Hippocampal infection is also associated with impaired cognitive ability, anxietylike behavior and memory impairment of TMEV-infected C57BL/ 6 mice (9, 51, 92) . Recently, it has been shown by Broer et al that the TMEV-BeAn substrain used in the present experiment did not elicit epileptic seizures in C57BL/6 mice (7). Similarly, we did not observe overt seizures in the present study. However, targeted diagnostic methods such as video/EEG monitoring and behavioral tests (eg, Morris water maze) are needed to detect subtle clinical changes and fully discover the functional relevance especially of prolonged hippocampal infection in C57BL/6 mice in future studies.
Our data reveal that Treg-expansion is associated with an accelerated recruitment of Foxp3 1 T cells to the hippocampus together with an increased Foxp3 mRNA expression during the acute TME phase, which is potentiated by simultaneous CD8-depletion (group Treg"CD8#TMEV). Explanations for this effect include an increased peripheral expansion of CD4 1 Foxp3 1 Treg following CD8-depletion, as observed in blood and lymphoid organs, as well as an enhanced Treg migration to the brain probably by an altered chemokine milieu in the hippocampus and/or increased expression of inflammatory homing receptors on Treg (98) . For instance, CCR5
1 Treg accumulate preferentially in the brain of Japanese encephalitis virus-infected mice (33) and CCR6 expression enhances the CNS influx of Treg in experimental autoimmune encephalomyelitis (38, 96) . Increased Treg responses in the CNS have the potential to alter the local environment, in which antiviral immunity is reduced by the release of inhibitory cytokines, like IL-10 and TGF-b, as demonstrated by RT-qPCR. Furthermore, Tregmediated cytokine consumption (IL-2 deprivation), disturbed antigen presenting cell function, and apoptosis of effector T cells might contribute to diminished protective immunity (31, 36, 53, 66, 95) .
Development of robust CD8-mediated cytotoxicity directed against dominant TMEV epitopes early after infection accounts for virus clearance and protection from demyelinating disease in resistant mouse strains (20, 21) . Genetic depletion of CD8 1 T cells has been shown to reduce antiviral immunity, which leads to TMEV persistence, prolonged inflammation and demyelination in the spinal cord of mice with a C57BL/6 background (21, 62, 71, 72) . Genetic b 2 -microglobulin deficiency, which results in disturbed MHC class I-restricted CD8
1 T cell responses, also predisposes resistant mouse strains to develop TMEV persistence and myelin loss (71, 72) . Moreover, similar to our findings, antibody-mediated depletion of CD8 1 T cells prior to TMEV infection has been shown to diminish viral clearance causing an increased severity of demyelinating disease in susceptible SJL mice and the presence of small demyelinating lesions in resistant C57BL/10SNJ mice, respectively (4, 73) . Strikingly, additional Treg-expansion significantly increases spinal cord infection and inflammation in aCD8-treated mice, indicative of enhanced virus spread within the CNS. Myelitis and myelin loss in combined treated C57BL/6 mice are associated with a preferential infection of the spinal cord white matter, resembling initial white matter lesions in SJL mice (26, 63, 87) . The switch of virus cell tropism from neurons to oligodendrocytes and microglia/macrophages in the white matter is a prerequisite for TMEV-IDD in susceptible mouse strains (41) . Although compared to white matter lesions in TMEV-IDD-susceptible SJL mice (25) relatively small-sized myelin lesions and mild cellular infiltrates were found in the spinal cord, our data revealed that chronic infection renders C57BL/6 mice susceptible to develop demyelinating leukomyelitis and axonal damage. The initiation of axon degeneration and axonal transport defects in TME is supposed to be virusinduced and might represent an active self-destructive response to limit further virus spread along spinal cord axons in susceptible mice. Accordingly, axonal damage due to prolonged virus infection might have contributed to myelin loss (inside-out hypothesis) in the present study. Similar to MS patients, axonal damage in infected mice is regarded to account for functional disability and has the ability to trigger immune-mediated myelin damage (39, 84, 86, 87) . Phenotyping of spinal cord infiltrates together with cytokine analyses also argues for the presence of CD4 1 T cell-mediated immunopathology in combined treated C57BL/6 mice. Moreover, release of myelinotoxic factors by activated CD107b 1 microglia/macrophages (bystander effects) following virus infection might have led to myelin and axonal damage (15) .
Similar to spinal cord lesions in SJL mice following TMEVinfection (90) , increased infiltration of CD3 1 T cells, CD45R 1 B cells, and CD107b 1 microglia/macrophages were found predominantly in the spinal cord white matter of combined treated animals at late disease stage (42 dpi); however, the amount of recruited immune cells was comparatively lower. Prolonged leukocyte infiltration was associated with an increased expression of the proinflammatory cytokines IL-1a and TNF-a. IL-1a is upregulated by microglia/macrophages in a variety of CNS disorders and initiates protective responses against certain viral infections, including TMEV-infection. However, excessive IL-1 signaling has been shown to induce pathogenic Th17 responses, rendering C57BL/6 mice susceptible to TMEV-IDD (32, 68) . Likewise, dual-probably disease phase dependent-functions are described also for TNF-a in TME with protective antiviral effects on the one hand and promoting Th1-mediated immunopathology on the other (28, 63, 74, 77) . Increased Foxp3
1 Treg recruitment together with enhanced IL-10 levels in the spinal cord of combined treated mice is suggestive of compensatory attempts to sustain CNS homeostasis and prevent collateral tissue damage, as observed in different autoimmune and infectious diseases (2, 37) . Noteworthy, Treg have been shown to increase IL-10 production and reduce inflammatory demyelination during chronic disease in TMEV-infected SJL mice (50, 70) .
Similar to the present findings, a protective role of CD8 1 T cells because of their contribution to viral clearance has been described in SJL mice infected with the BeAn strain, determined by antibody-mediated CD8-depletion during early and late TME (4) . A recovering CD8
1 T cell population following antibody treatment might re-establish protective antiviral immunity, which can explain the rather mild spinal cord inflammation in combined treated C57BL/6 mice compared to fully susceptible SJL mice in the chronic phase (42 dpi). Strikingly, Treg-expansion reduces the frequency of circulating CD8
1 T cells in C57BL/6 mice (group Treg"TMEV) and delays the recovery of peripheral CD8
1 T cells and their recruitment to the spinal cord in combined treated mice (group Treg"CD8#TMEV). Treg have the ability to reversibly suppress cytotoxic T cell expansion, for example, via TGF-b signaling and IL-2 deprivation (54, 55, 66) . In infectious diseases, Treg directly inhibit virus-specific effector CD8
1 T cells as demonstrated in friend retrovirus-infected C57BL/6 mice (100). Moreover, depletion of Treg in DEREG mice combined with antibodymediated blockade of inhibitory receptors (PD-1 ligand, TIM-3) reactivates exhausted CD8
1 T cells and efficiently reduces the chronic load of friend retrovirus (16) . Thus it can be speculated that strengthened Treg-responses following IL-2C treatment (Tregexpansion) cause delayed recovery of peripheral CD8
1 T cell population and impaired development of TMEV-specific effector T cell responses in aCD8-treated C57BL/6 mice. Referring to this, early rapid expansion of Foxp3 1 cells in SJL mice has been shown to induce a disturbed ratio of CD8 1 effector T cells to Treg, which is supposed to cause diminished TMEV-specific immune responses and virus persistence in TME-IDD susceptible mouse strains (70) .
In conclusion, results revealed synergistic effects of Tregexpansion and cytotoxic T cell-ablation to delay viral elimination in C57BL/6 mice, which partly mimics the immunological situation and neuropathology in TMEV-IDD-susceptible mouse strains. Reduced antiviral immunity can exacerbate CNS infection, potentiating the risk of immune-mediated myelin damage via bystander demyelination and epitope spreading (49) . Therefore, novel Tregbased approaches to treat diseases with an infectious etiology or those that develop in parallel with viral infection are at increased risk of disease exacerbation, particularly in individuals with inherited or acquired CD8-deficiencies and impaired protective cytotoxicity (81, 99) .
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Additional Supporting Information may be found in the online version of this article at the publisher's web-site: Table S1 . Results of statistical analyses (P-values)-TMEVinfected animals. Table S2 . Results of statistical analyses (P-values)-Comparison between combined treated, TMEV-infected C57BL/6 mice (group Treg"CD8#TMEV) and TMEV-infected SJL mice (group SJL TMEV). Table S3 . Results of statistical analyses (P-values)-noninfected mice. Mann-Whitney U test) are labeled: * significant difference to group TMEV; # significant difference to group Treg"TMEV; ᭺ significant difference to group CD8#TMEV. TMEV 5 untreated, infected mice; Treg"TMEV 5 regulatory T cell expanded, infected mice; CD8#TMEV 5 CD8 1 T cell depleted, infected mice; Treg"CD8#T-MEV 5 combined treated, infected mice. Figure S3 . Quantification of CD45R
1 B cells in the spleen of Theiler's murine encephalomyelitis virus (TMEV)-infected C57BL/6 mice. (A) Percentage of area in the spleen stained by CD45R-specific immunohistochemistry. Box plots display median and quartiles with minimum and maximum values. Significant differences (P 0.05; Mann-Whitney U test) are labeled: * significant difference to group TMEV; TMEV 5 untreated, infected mice; Treg"TMEV 5 regulatory T cell expanded, infected mice; CD8#TMEV 5 CD8 1 T cell depleted, infected mice; Treg"CD8#TMEV 5 combined treated, infected mice. Figure S4 . Quantification of Foxp3 1 regulatory T cells in lymphoid organs of non-infected C57BL/6 mice (steady state conditions). Analysis of Foxp3 1 regulatory T cells in the (A-C) spleen, (D-F) thymus and (G-I) cervical lymph node. Representative images of (B,E,H) an untreated control mouse and (C,F,I) combined treated mouse (group Treg"CD8#) at day 3. Note marked increase of labeled cells (brown signal) in all organs in combined treated animal. (A,D,G). Box plots display median and quartiles with minimum and maximum values. Significant differences (P 0.05; Mann-Whitney U test) are labeled: * significant difference to control group; # significant difference to group Treg"; control 5 untreated mice; Treg" 5 regulatory T cell expanded mice; Treg"CD8# 5 combined treated mice.
